Breast cancer and bone mineral density: The Marburg Breast Cancer and Osteoporosis Trial (MABOT II)

References

• Who are candidates for prevention and treatment for osteoporosis? Osteoporos Int 1997;7:1–6
   Web of Science ®Google Scholar
• Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277–300
   PubMed Web of Science ®Google Scholar
• Coughlin SS, Ekwueme DU. Breast cancer as a global health concern. Cancer Epidemiol 2009;33:315–18
   PubMed Web of Science ®Google Scholar
• Hadji P, Gottschalk M, Ziller V, Kalder M, Jackisch C, WagnerU. Bone mass and the risk of breast cancer: the influence of cumulative exposure to oestrogen and reproductive correlates. Results of the Marburg breast cancer and osteoporosis trial (MABOT). Maturitas 2007;56:312–21
   PubMed Web of Science ®Google Scholar
• Nguyen ND, Ahlborg HG, Center JR, Eisman JA, Nguyen TV. Residual lifetime risk of fractures in women and men. J Bone Miner Res 2007;22:781–8
   PubMed Web of Science ®Google Scholar
• Chen Z, Arendell L, Aickin M, Cauley J, Lewis CE, Chlebowski R. Hip bone density predicts breast cancer risk independently of Gail score: results from the Women's Health Initiative. Cancer 2008;113:907–15
   PubMed Web of Science ®Google Scholar
• Hadji P, Ziller M, Maskow C, Albert U, Kalder M. The influence of chemotherapy on bone mineral density, quantitative ultrasonometry and bone turnover in pre-menopausal women with breast cancer. Eur J Cancer 2009;45:3205–12
   PubMed Web of Science ®Google Scholar
• Stewart A, Kumar V, Torgerson DJ, Fraser WD, Gilbert FJ, Reid DM. Axial BMD, change in BMD and bone turnover do not predict breast cancer incidence in early postmenopausal women. Osteoporos Int 2005;16:1627–32
   PubMed Web of Science ®Google Scholar
• Tremollieres FA, Pouilles JM, Laparra J, Ribot C. Bone mineral density at menopause does not predict breast cancer incidence. Osteoporos Int 2008;19:1497–504
   PubMed Web of Science ®Google Scholar
• Kuller LH, Cauley JA, Lucas L, Cummings S, Browner WS. Sex steroid hormones, bone mineral density, and risk of breast cancer. Environ Health Perspect 1997;105(Suppl 3):593–9
   PubMed Web of Science ®Google Scholar
• Chen Z, Maricic M, Bassford TL, et al. Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study. Arch Intern Med 2005;165:552–8
   PubMed Web of Science ®Google Scholar
• Kanis JA, McCloskey EV, Powles T, Paterson AH, Ashley S, Spector T. A high incidence of vertebral fracture in women with breast cancer. Br J Cancer 1999;79:1179–81
   PubMed Web of Science ®Google Scholar
• Kanis JA, Johnell O. Requirements for DXA for the management of osteoporosis in Europe. Osteoporos Int 2005;16:229–38
   PubMed Web of Science ®Google Scholar
• Bauer DC, Gluer CC, Cauley JA, et al. Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women. A prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med 1997;157:629–34
   PubMed Web of Science ®Google Scholar
• Hans D, Argent-Molina P, Schott AM, et al. Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet 1996;348:511–14
   PubMed Web of Science ®Google Scholar
• Hadji P, Hars O, Schuler M, et al. Assessment by quantitative ultrasonometry of the effects of hormone replacement therapy on bone mass. Am J Obstet Gynecol 2000;182:529–34
   PubMed Web of Science ®Google Scholar
• Hadji P, Hars O, Bock K, et al. Age changes of calcaneal ultrasonometry in healthy German women. Calcif Tissue Int 1999;65:117–20
   PubMed Web of Science ®Google Scholar
• Hadji P, Hars O, Wuster CB Stiffness index identifies patients with osteoporotic fractures better than ultrasound velocity or attenuation alone. Maturitas 1999;31:221–6
   PubMed Web of Science ®Google Scholar
• Krebs in Deutschland 2003–2004 Haeufigkeiten und TrendsBerlin: Robert Koch-Institut2008
   Google Scholar
• Ng DC, Sundram FX. Bone mineral density – correlation between quantitative ultrasound characteristics and dual energy X-ray absorptiometry. Ann Acad Med Singapore 1998;27:524–6
   PubMedGoogle Scholar
• Olsson H, Hägglund G. Reduced cancer morbidity and mortality in a prospective cohort of women with distal forearm fractures. Am J Epidemiol 1992;136:422–7
   PubMed Web of Science ®Google Scholar
• Persson I, Adami HO, McLaughlin JK, Naessen T, Fraumeni JF Jr. Reduced risk of breast and endometrial cancer among women with hip fractures (Sweden). Cancer Causes Control 1994;5:523–8
   PubMed Web of Science ®Google Scholar
• Zhang Y, Kiel DP, Kreger BE, et al. Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med 1997;336:611–17
   PubMed Web of Science ®Google Scholar
• Cauley JA, Lucas FL, Kuller LH, Vogt MT, Browner WS, Cummings SR. Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. JAMA 1996;276:1404–8
   PubMed Web of Science ®Google Scholar
• Bruning PF, Pit MJ, de Jong-Bakker M, van den EA, Hart A, van EA. Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer. Br J Cancer 1990;61:308–10
   PubMed Web of Science ®Google Scholar
• Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 1995;87:190–7
   PubMed Web of Science ®Google Scholar
• Fox KM, Magaziner J, Sherwin R, et al. Reproductive correlates of bone mass in elderly women. Study of Osteoporotic Fractures Research Group. J Bone Miner Res 1993;8:901–8
   PubMedGoogle Scholar
• Richelson LS, Wahner HW, Melton LJ, III, Riggs BL. Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. N Engl J Med 1984;311:1273–5
   PubMed Web of Science ®Google Scholar
• Chen Z, Maricic M, Aragaki AK, et al. Fracture risk increases after diagnosis of breast or other cancers in postmenopausal women: results from the Women's Health Initiative. Osteoporos Int 2009;20:527–36
   PubMed Web of Science ®Google Scholar
• Adami HO, Zack M, Kressner U, et al. Hip fractures in women with breast cancer. Am J Epidemiol 1990;132:877–83
   PubMed Web of Science ®Google Scholar
• Utz JP, Melton LJ, III, Kan SH, Riggs BL. Risk of osteoporotic fractures in women with breast cancer: a population-based cohort study. J Chronic Dis 1987;40:105–13
   PubMedGoogle Scholar
• Helzlsouer KJ, Alberg AJ, Bush TL, Longcope C, Gordon GB, Comstock GW. A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev 1994;18:79–85
   PubMedGoogle Scholar
• van Daele PL, Stolk RP, Burger H, et al. Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam Study. Ann Intern Med 1995;122:409–14
   PubMed Web of Science ®Google Scholar
• Dorgan JF, Longcope C, Stephenson HE, et al. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiol Biomarkers Prev 1996;5:533–9
   PubMed Web of Science ®Google Scholar
• Kerlikowske K, Shepherd J, Creasman J, Tice JA, Ziv E, Cummings SR. Are breast density and bone mineral density independent risk factors for breast cancer? J Natl Cancer Inst 2005;97:368–74
   PubMed Web of Science ®Google Scholar